Puma Biotechnology reported $-44672000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Amgen AMGN:US $ 1884M 1420M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Array Technologies Inc ARRY:US -25552000 25.54M
Biogen BIIB:US $ 329.2M 119.3M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Clovis Oncology CLVS:US $ -67.41M 0.96M
Daiichi Sankyo 4568:JP Y 27246M 7974M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Exelixis EXEL:US $ 38.2M 57.89M
Gilead Sciences GILD:US $ 2592M 1070M
Glaxosmithkline GSK:US $ 1168M 227M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Macrogenics MGNX:US $ -52.89M 12.95M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Moderna Inc MRNA:US 3.33B 553M
Novartis NOVN:VX SF 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Puma Biotechnology PBYI:US $ -44.67M 39.57M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Seattle Genetics SGEN:US $ -293.85M 209.27M
Spectrum Pharmaceuticals SPPI:US $ -33.08M 17.05M
Takeda 4502:JP Y 45965M 154412M
Tg Therapeutics TGTX:US $ -85.64M 7.14M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vanda Pharmaceuticals VNDA:US $ 7.77M 1.88M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
YTE INCY:US $ 181.74M 32.28M